Finance

Beta
Lists
377740:KRX
BioNote Inc
₩4,765.00
-2.36%
(-115.00) 1D
Jun 17, 2:43:31 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 377740...
Open
₩4,880
High
₩4,960
Low
₩4,660
Mkt. cap
485.49B
Avg. vol.
87.04K
Volume
48.03K
Dividend
4.78%
Quarterly dividend
₩57
Ex-dividend date
Mar 28, 2025
52-wk high
₩6,320
52-wk low
₩4,435
EPS
-₩505
Shares outstanding
101.89M
No. of employees
366
Open
₩4,880
High
₩4,960
Low
₩4,660
Mkt. cap
485.49B
Avg. vol.
87.04K
Volume
48.03K
Dividend
4.78%
Quarterly dividend
₩57
Ex-dividend date
Mar 28, 2025
52-wk high
₩6,320
52-wk low
₩4,435
EPS
-₩505
Shares outstanding
101.89M
No. of employees
366
News stories
From sources across the web
About BioNote Inc
CEO-
Employees366
Founded2003
Headquarters-
SectorBiotechnology
Websitebionote.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
32.41B
29.50B
27.97B
32.57B
Cost of goods sold
14.70B
12.01B
12.74B
13.40B
Cost of revenue
14.70B
12.01B
12.74B
13.40B
Research and development expenses
3.63B
4.81B
4.90B
4.38B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.98B
6.73B
8.13B
7.53B
Operating expense
11.35B
12.67B
14.29B
12.82B
Total operating expenses
26.05B
24.68B
27.03B
26.21B
Operating income
6.35B
4.82B
943.29M
6.35B
Other non operating income
-18.69M
23.78M
51.74M
24.81M
EBT including unusual items
87.86B
19.78B
-201.23B
41.56B
EBT excluding unusual items
95.13B
16.82B
-92.65B
30.33B
Income tax expense
3.32B
1.84B
-7.24B
264.80M
Effective tax rate
3.78%
9.31%
3.60%
0.64%
Other operating expenses
34.30M
85.19M
31.83M
17.17M
Net income
84.53B
17.94B
-194.00B
41.30B
Net profit margin
260.85%
60.82%
-693.53%
126.82%
Earnings per share
-
-
-
-
Interest and investment income
3.51B
3.85B
3.59B
3.83B
Interest expense
-79.86M
-75.60M
-45.41M
-40.21M
Net interest expenses
3.43B
3.78B
3.55B
3.79B
Depreciation and amortization charges
391.31M
515.96M
553.97M
535.82M
EBITDA
8.60B
7.21B
3.41B
8.83B
Gain or loss from assets sale
-129.82M
-67.10M
1.88B
1.10M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer